在一个患有呼吸衰竭的移民儿童身上出现了新的LMNA突变
John Chukwuma Martin-Agba1, Elohor Omoefe Okoro1, Owora Amadi1
1Emergency Department, Royal Manchester Children's Hospital, Manchester, UK.
BMJ case reports
|April 22, 2025
概括
一个患有未诊断的肌肉缩症的孩子患有呼吸衰竭. 基因检测发现了一种致病性LMNA变体,证实了Emery-Dreifuss肌肉发育不良 (EDMD). 早期诊断对于管理心脏和肌肉并发症至关重要.
科学领域:
- 儿科神经学 儿科神经学
- 临床遗传学 临床遗传学
背景情况:
- 一个无意识的孩子的病例介绍,患有未被诊断的肌肉发育不良和粗运动技能的回归.
- 患者出现呼吸衰竭,急性发烧性疾病和改变的传感器,需要紧急医疗干预.
- 这名儿童的总运动功能分类系统 (GMCFS) 五级,表明严重的运动障碍.
研究的目的:
- 为了确定患者进展性神经肌肉疾病的潜在遗传原因.
- 突出基因检测在诊断罕见神经肌肉疾病中的重要性.
- 强调埃米里-德莱法斯肌肉发育不良症 (EDMD) 的临床特征和治疗方法.
主要方法:
- 临床评估和详细的病史.
- 基因检测,特别是对致病变体的测序.
- 患者护理和监测的多学科团队方法.
主要成果:
- 遗传分析显示了一种致病性LMNA误解变体 (NM_170707.2:c.1072G>A p.Glu358Lys).
- 这种变体与埃米里-德莱法斯肌肉发育不良症 (EDMD) 相关,这种疾病的特征是关节收缩,肌肉疲软和心脏参与.
- 目前,该患者正在接受多学科随访,并进行心脏监测.
结论:
- 该案例强调了早期诊断EDMD对于预防严重的心脏并发症和管理合症的重要性.
- 迅速识别LMNA变异的基因有助于适当的诊断和管理计划.
- 多学科护理对于优化EDMD儿童的治疗结果至关重要.
更多相关视频
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
49.4K
04:56Laryngeal Mask Airway LMA Placement in a Neonatal Patient Simulator Using a Non-Inflatable Supraglottic Airway SGA
Published on: July 14, 2023
1.7K
相关概念视频
Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
